Search results
Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer...
Benzinga via Yahoo Singapore Finance· 6 days agoOn Thursday, Roche Holdings AG (OTC:RHHBY) said that the Phase 2/3 SKYSCRAPER-06 study of...
Roche's (RHHBY) Combo Therapy Misses Lung Cancer Study Goals
Zacks via Yahoo Singapore Finance· 7 days agoRoche (RHHBY) announces that its mid to late-stage lung cancer study evaluating the tiragolumab...
Here's Why Sarepta (SRPT) Stock Price Surged 57% YTD
Zacks via Yahoo Singapore Finance· 2 days agoTreatment with the Pfizer therapy failed to improve motor function among the DMD boys. Pfizer plans to share more detailed results from the study at an...
The best 4th of July sales you can still shop — save up to 70% at Amazon, Walmart, Target and more
Yahoo Life Shopping· 6 days agoTrue Botanicals: Score up to 35% off selections from the brand's gentle-yet-effective skin-care line...